Azikem 500, a potent form of Azithromycin, is a cornerstone in modern antibiotic therapy. Its mechanism involves inhibiting protein synthesis in bacteria, making it indispensable for treating respiratory tract infections, skin infections, and certain STIs. At Jiangxi Serum Pharma, we prioritize Information Gain by providing clinicians and partners with verified pharmacodynamic data and impurity profiles that exceed industry standards.
Our manufacturing resilience relies on a robust ecosystem of GMP-certified facilities. By leveraging advanced bio-fermentation and co-crystallization technologies, we ensure that every batch of Azikem 500 maintains high bio-availability and consistent shelf-life, crucial for global pharmaceutical procurement.
The pharmaceutical landscape is shifting toward personalized dosing and rapid delivery systems. Our R&D team is currently focusing on "Pre-Mix" optimizations to facilitate smoother clinical applications in resource-constrained regions, effectively bridging the gap between high-tech manufacturing and humanitarian healthcare needs.
A: It is primarily used for bacterial infections, including pneumonia, pharyngitis, and skin infections. It is highly valued for its long half-life, allowing for once-daily dosing.
A: We adhere strictly to BP/USP/GMP standards, with rigorous internal audits and third-party testing protocols for all exported APIs and finished dosage forms.
